Walk into any state veterinary conference in the last two years and the hallway conversations sound the same. Who’s buying what? What Mars paid. Whether the associate at the practice down the road is making more under a corporate structure. And underneath all of it, the question that associate veterinarians who want to own their own business keep circling but rarely ask out loud is: did corporate consolidation already win, or is the independent route still viable?
Independent veterinary practices for sale still represent the majority of the veterinary acquisition market — and the buyers who understand where corporate groups have pulled back are finding the best opportunities in 2026 with the least competition. A peer-reviewed analysis published in Frontiers in Veterinary Science in May 2025 concluded that current economic conditions are specifically favorable for a resurgence of independent veterinary practice ownership. The data supports that conclusion.
The Consolidation Picture — and Where Corporate Groups Have Gone Selective:
Corporate ownership of U.S. veterinary practices has grown from roughly 10% of the market in 2017 to approximately 30% by late 2022, representing a remarkable shift in the industry’s ownership landscape according to the American Veterinary Medical Association. Some estimates for 2025 place the figure higher as acquisition activity has continued. Specialty practices — cardiology, oncology, emergency services — now sit at approximately 75% corporate ownership.
That’s the part of the story most buyers already know. What most don’t know is that corporate consolidators have become significantly more selective about which practices they pursue. Most major PE-backed consolidators publicly describe their target acquisition profile as multi-doctor practices with at least $2 million in revenue, per Capstone Partners’ market commentary and Octus sector research. Higher interest rates have made debt-financed acquisitions more expensive for corporate groups, with some consolidators pulling back and focusing on larger or more profitable practices rather than acquiring broadly.
That $2 million revenue threshold is the most important number an individual buyer can know in 2026. It defines exactly where institutional buyers are concentrated — and by exclusion, exactly where they aren’t.
Where the $2M Threshold Leaves the Door Open:
A single-doctor general practice generating $700,000 to $1.2 million annually doesn’t clear what most corporate buyers need to justify their transaction costs and return targets. They’re not losing a competition for that practice. They’re not in the competition.
In Texas, this creates an opening the headline consolidation numbers hide entirely. According to AVMA data drawn from a 2024 survey of 6,000 veterinary practices, approximately 65% of general practices remain independently owned. Vet practice for sale Texas listings in markets like Lubbock, Tyler, Waco, or Beaumont aren’t attracting multi-bidder corporate processes. They’re attracting individual buyers who show up prepared. Veterinary practice ownership Texas in secondary markets means buying into loyal, community-rooted client bases with sellers who have been thinking quietly about their exit for two or three years—not auction-style processes where institutional capital sets the price.
That is not a secondary prize. For the buyer with the right preparation, it’s the better market.
Why Seller Psychology Has Shifted in Independent Buyers’ Favor:
Here’s what almost nobody is writing about: some of the most compelling acquisition opportunities in 2026 are coming from owners who were approached by corporate groups during the consolidation peak and said no—not because the price was wrong, but because they watched what happened to colleagues who said yes.
Post-sale corporate employment surprised many practice owners who expected clinical autonomy and found production targets instead. Research published in the Journal of the American Veterinary Medical Association documented that the ability of corporations to increase employee benefits has not always translated into reality, with some veterinary professionals reporting worse benefits after their practice transitioned to corporate ownership. Owners who witnessed that firsthand are now approaching their exit with a specific buyer in mind—someone who will carry on what they built rather than fold it into a regional network’s operating model.
A seller who wants to sell my veterinary practice to another veterinarian, on those terms, is not chasing the maximum multiple. They’re chasing the right buyer. For an individual buyer who represents exactly that profile, that preference is not sentiment—it’s a competitive advantage that translates into access, reduced competition, and deal structure flexibility that doesn’t require winning a bidding process against institutional capital.
What Independent Ownership Produces That a Corporate Role Cannot:
The financial case starts with the acquisition multiple. Small practices typically sell at 5x to 7x EBITDA for individual buyers—a range that makes ownership economics work at practice sizes well below what corporate groups target. A practice purchased at these multiples is a wealth-building vehicle of a fundamentally different character than a salary at a corporate clinic, even if the corporate salary looks favorable in year one. Ownership compounds. Employment doesn’t.
And for buyers carrying student debt — which describes most associate veterinarians in their early careers — the financial model still works at these practice sizes. The debt service on a well-structured acquisition, combined with a practice’s operating cash flow, typically supports ownership economics that compare favorably to employment, particularly as the practice grows and the buyer builds equity.
The lifestyle case is equally concrete. Independent owners choose their appointment length, their service mix, how they staff, and how they price. Veterinary practices for sale at this scale are not massive institutional operations — they’re practices where the owner’s clinical philosophy shapes every day of operation. That control is what many veterinarians discover they valued far more than their associate salary reflected.
How Buyer Representation Changes the Outcome:
Individual buyers without representation enter a market where sellers almost always have professional brokerage support on their side. The information asymmetry is real: valuation context, comparable transaction data, and off-market opportunities all sit with people who work these deals daily.
A buyer representative who specializes in veterinary acquisitions closes that gap. They identify practices matching a buyer’s criteria before those practices reach public platforms. They build the independent financial model that distinguishes a fairly priced practice from one whose asking price doesn’t survive scrutiny. And in a market where seller preference for a vet-to-vet transition is running higher than it has in years, they know which sellers that applies to and how to approach that conversation in a way that opens doors.
Frequently Asked Questions:
FAQ 1. Do corporate groups compete with individual buyers for smaller general practices in 2026?
Generally no. Most PE-backed consolidators target practices with at least $2 million in annual revenue. A single-doctor general practice in a secondary market may attract one or two qualified individual buyers—not a team of corporate acquisition analysts running a competitive process. That difference in the buyer pool is the core of the individual buyer’s advantage right now.
FAQ 2. What types of sellers are most likely to prefer an independent buyer in 2026?
Owners whose practice size doesn’t generate meaningful corporate interest, owners approaching retirement who watched peers navigate post-sale corporate employment and prefer a different exit, and owners who built a specific clinical culture and want continuity of it after they leave. These sellers are more common than the consolidation headlines suggest, and they represent the most accessible acquisition opportunities for individual buyers.
FAQ 3. Is now a good time to sell vet practice to an independent buyer rather than waiting for corporate interest?
For practices below the $2M revenue threshold, waiting for significant corporate interest may mean waiting indefinitely—not because the practice lacks value, but because it doesn’t fit institutional acquisition economics. An independent buyer who shows up prepared, pre-qualified, and with a clear transition plan is the right match for this practice type. The best practices in this segment don’t stay available while buyers wait on timing.
Final Thoughts:
The consolidation narrative runs so loud that it obscures what’s actually happening in the majority of the market. Independent veterinary practice transitions between veterinarians—owner to owner, without corporate intermediaries—are happening at a pace the headlines don’t capture because they don’t generate press releases. Sell vet practice activity in this segment is real, active, and moving toward buyers who are prepared. The buyers who understand where the competition isn’t and show up with the right representation aren’t playing a secondary game. It generates ownership. It generates equity. It generates careers.
